The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients
Lisianyĭ, N.I.; Romodanov, S.A.; Radzievskiĭ, A.A.; Rudenko, V.A.; Pedachenko, E.G.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 3: 16-18
1991
ISSN/ISBN: 0042-8817 PMID: 1661534 Document Number: 372703
Clinical observations over 48 neurosurgical patients with infectious inflammatory complications and study of their immune status showed that a course of immunocorrective therapy with myelopid produces a favourable clinical effect and normalizes the patient's immune status. Myelopid causes the best normalizing effect in patients with nontumorous pathology of the central nervous system and in extracerebral neoplasms.